759 |
Utility and Pitfalls of Composite and Surrogate Endpoints in Clinical Trials |
Helen Parise |
Jul. 22. 09 |
758 |
Randomized Trials vs. Observational Registries: Strengths and Weaknesses |
David Joel Cohen |
Jul. 22. 09 |
757 |
Non-Invasive Imaging Is More Clinically Relevant ! |
James K. Min |
Jul. 22. 09 |
756 |
Percutaneous Therapy of Structural Heart Disease Using Imaging Modality |
Ted Feldman |
Jul. 21. 09 |
755 |
Vulnerable Plaque Trials Using Surrogate Imaging Marker |
Patrick W. Serruys |
Jul. 21. 09 |
754 |
SPECT and PET Imaging: How Useful for PCI Patients |
Won-Jun Kang |
Jul. 21. 09 |
753 |
On-Line 4D CT Reconstruction for Planning and Executing Complex Structural Heart Disease Intervention |
Howard A. Cohen |
Jul. 21. 09 |
752 |
Current and Future Role of CT/MRI Imaging for Screening Asymptomatic CAD and Triaging ACS Patients |
James K. Min |
Jul. 21. 09 |
751 |
Endothelial Dysfunction Associated with DES: How Important? |
Alan C. Yeung |
Jul. 21. 09 |
750 |
OCT and Vascular Healing Following DES Implantation: Insights form Histology |
Juan F. Granada |
Jul. 21. 09 |